中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

671 records (took 0.024 seconds)

    Ophthalmic disease detection apparatus
    121.
    发明授权
    Ophthalmic disease detection apparatus 失效
    眼科疾病检测仪

    公开(公告)号：US4832043A

    公开(公告)日：1989-05-23

    申请号：US111014

    申请日：1987-10-20

    Applicant: Tadashi Ichihashi

    Inventor： Tadashi Ichihashi

    IPC: A61B3/10 ,  A61B3/117 ,  A61B3/12

    CPC classification number: A61B3/117 ,  A61B3/10

    Abstract: An apparatus for detecting ophthalmic diseases such as an inflammation in a patient's eye which includes a laser beam focussed at a selected spot in the eye. The light scattered from the eye is photoelectrically detected and converted into an electrical signal which is subsequently used to determine the protein concentration essential to ophthalmic disease detection in the patient's eye. The laser beam is deflected to scan the eye so far as to exceed a detection slit. The electrical signal derived when the laser beam is deflected outside the slit is used to remove noises from the electrical signal.

    Abstract translation: 一种用于检测患者眼睛中的眼部疾病如眼睛疾病的装置，其包括聚焦在眼睛中的选定位置的激光束。 从眼睛散射的光被光电检测并转换成电信号，其随后用于确定患者眼中眼科疾病检测所必需的蛋白质浓度。 激光束被偏转以扫描眼睛，以至于超过检测狭缝。 当激光束在狭缝外偏转时导出的电信号用于从电信号中去除噪声。

    Method and apparatus for inspecting printed circuit board
    122.
    发明授权
    Method and apparatus for inspecting printed circuit board 失效
    检查印刷电路板的方法和装置

    公开(公告)号：US4758782A

    公开(公告)日：1988-07-19

    申请号：US905922

    申请日：1986-09-10

    Applicant: Kouji Kobayashi

    Inventor： Kouji Kobayashi

    IPC: H05K3/00 ,  G01N21/956 ,  G01R31/28 ,  G01R31/309 ,  G06T1/00 ,  G01R31/02

    CPC classification number: G01N21/956 ,  G01N21/95607 ,  G01R31/2806 ,  G01R31/309 ,  G01N2021/95638

    Abstract: Method and apparatus for inspecting a printed circuit board wherein scanned image data are digitized and analyzed according to a feature extraction method and a mutual comparison method. The result of both of the analysis methods is combined with predetermined conditions to control output devices including a CRT display or a marking device. The two complementary methods compensate each others drawbacks so that the reliability of inspection can be improved.

    Abstract translation: 根据特征提取方法和相互比较方法对扫描图像数据进行数字化和分析的印刷电路板的检查方法和装置。 两种分析方法的结果与预定条件相结合，以控制包括CRT显示器或标记装置的输出装置。 这两种互补方法相互补偿的缺点，从而可以提高检查的可靠性。

    2'-N-.beta.-Lysyl) aminoglycosides
    124.
    发明授权
    2'-N-.beta.-Lysyl) aminoglycosides 失效
    2'-N-β-赖氨酰）氨基糖苷类

    公开(公告)号：US4487924A

    公开(公告)日：1984-12-11

    申请号：US494556

    申请日：1983-05-13

    Applicant: Isamu Watanabe ,  Kazuhiro Kamiya ,  Toshihito Mori

    Inventor： Isamu Watanabe ,  Kazuhiro Kamiya ,  Toshihito Mori

    IPC: A61K31/70 ,  A61K31/7028 ,  A61K31/7034 ,  A61K31/7036 ,  A61P31/04 ,  C07H15/224 ,  C07H15/22

    CPC classification number: C07H15/224

    Abstract: A compound of the following formula ##STR1## wherein each of R.sub.1, R.sub.2 and R.sub.3 represents H or CH.sub.3, R.sub.4 represents H or C.sub.2 -C.sub.4 acyl substituted at the 2-, 3- or 4-position by an amino group, and Y represents ##STR2## provided that R.sub.1 and R.sub.2 are not CH.sub.3 at the same time, and an acid addition salt thereof; and a process for the production thereof.

    Abstract translation: 下式（I）的化合物，其中R 1，R 2和R 3各自表示H或CH 3，R 4表示H或被2-，3-或4-位被氨基取代的C 2 -C 4酰基， 并且Y表示，条件是R1和R2不同时为CH3，及其酸加成盐; 及其生产方法。

    Fortimicin aminoglycosides, process for production thereof, and use thereof
    126.
    发明授权
    Fortimicin aminoglycosides, process for production thereof, and use thereof 失效
    百古霉素氨基糖苷类，其制备方法及其用途

    公开(公告)号：US4255421A

    公开(公告)日：1981-03-10

    申请号：US85058

    申请日：1979-10-12

    Applicant: Isamu Watanabe ,  Akio Iwasaki ,  Toshihito Mori

    Inventor： Isamu Watanabe ,  Akio Iwasaki ,  Toshihito Mori

    IPC: C07H15/224 ,  A61K31/71 ,  C07H15/22

    CPC classification number: C07H15/224

    Abstract: Novel aminoglycosides of the following formula ##STR1## wherein R.sub.1 and R.sub.2 are identical or different and each represents a hydrogen atom or a methyl group, R.sub.3 represents a hydrogen atom or an optionally substituted aminoacyl group having 2 to 4 carbon atoms in the acyl moiety, and when all of R.sub.1, R.sub.2 and R.sub.3 are hydrogen atoms, the methylamino group at the 4-position is not oriented trans to the hydroxyl groups at the 3- and 5-positions; and acid addition salts thereof, which are useful as antibiotics; and process for producing compounds containing the same.

    Abstract translation: 下列通式的新型氨基糖苷类其中R 1和R 2相同或不同，各自表示氢原子或甲基，R 3表示酰基部分中的氢原子或任选取代的具有2至4个碳原子的氨基酰基， 当R 1，R 2和R 3全部为氢原子时，4-位上的甲基氨基不反向在3-和5-位羟基上; 和其酸加成盐，其可用作抗生素; 以及制备含有该化合物的化合物的方法。

    Isoindoline derivatives and the acid addition salts thereof and process for the preparation of same
    127.
    发明授权
    Isoindoline derivatives and the acid addition salts thereof and process for the preparation of same 失效
    异二氢吲哚衍生物及其酸加成盐及其制备方法

    公开(公告)号：US4115398A

    公开(公告)日：1978-09-19

    申请号：US757028

    申请日：1977-01-05

    Applicant: Koji Nakamura ,  Haruo Otaki ,  Yutaka Yamamoto ,  Noboru Shimizu ,  Kiyoshi Kawamura ,  Seiichi Sato

    Inventor： Koji Nakamura ,  Haruo Otaki ,  Yutaka Yamamoto ,  Noboru Shimizu ,  Kiyoshi Kawamura ,  Seiichi Sato

    IPC: C07D209/44

    CPC classification number: C07D209/44

    Abstract: Isoindoline derivatives of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein R represents a moiety selected from the group consisting of hydrogen, halogen, lower alkyl, lower alkoxy, nitro, hydroxy and hydroxy lower alkyl, and n is a positive number from 1 to 3, which R's may be the same or different when n is 2 or 3, and when n is 2, the two R's may be joined to the carbon atom vicinal to the phenyl ring to which the two R's are joined and may taken together form lower alkylenedioxy and the group ##STR2## and R.sub.1 is a member of the group consisting of hydrogen and lower alkyl.The compounds of this invention can be readily prepared by reacting a compound of the formula ##STR3## wherein R represents, in addition to the above defined, alkoxycarbonyloxy; R.sub.1 and n are as defined above; and X is halogen or the groups --O--SO.sub.2 --Y where Y is either lower alkyl or aryl, with isoindoline of the formula ##STR4## or a minemal acid salt thereof. The compounds are useful in such fields as, for example cardiovascular drugs.

    Abstract translation: 式（I）的异二氢吲哚衍生物及其药学上可接受的酸加成盐，其中R表示选自氢，卤素，低级烷基，低级烷氧基，硝基，羟基和羟基低级烷基的部分，和 n是1至3的正数，当n为2或3时，R可以相同或不同，当n为2时，两个R可以连接到苯环附近的碳原子上， R的连接可以一起形成低级亚烷基二氧基和基团，R 1是由氢和低级烷基组成的组的成员。

    MEDICAL PROGRAM AND MEDICAL EXAMINATION SYSTEM
    129.
    发明申请
    MEDICAL PROGRAM AND MEDICAL EXAMINATION SYSTEM 有权

    公开(公告)号：US20250030814A1

    公开(公告)日：2025-01-23

    申请号：US18569580

    申请日：2022-06-16

    Applicant: Kowa Company, Ltd.

    Inventor： Takahiro SUZUKI ,  Atsushi KAKUUCHI

    IPC: H04N5/91 ,  A61B3/00 ,  A61B3/14 ,  G06T7/00 ,  G16H30/20 ,  G16H40/67

    Abstract: Provided is a non-statutory computer-readable medium storing thereon a medical program for implementing various kinds of processing in a terminal device used together with a medical examination device including an imaging camera, in order to play a video live and record the video, while maintaining usability of the medical examination device including the imaging camera, the video being generated by imaging by the medical examination device. The medical program, when executed, causes a processor of the terminal device to perform: playing video data live and displaying the video data on a display unit of the terminal device, the video data being captured and simultaneously transmitted in real time by the medical examination device; and controlling start/stop of recording of the video data that is currently played live based on a predetermined operation.

Patent Agency Ranking